Robin Reschke

18PUBLICATIONS
20CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyCancer diagnosisGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jan 27, 2026
Autoantibodies as predictors for immune-related adverse events in checkpoint inhibition therapy of metastatic melanoma.

Robin Reschke, Petra Budde, Hans-Dieter Zucht

|Apr 10, 2025
Adiponectin to the rescue: extracorporeal photopheresis for managing immune checkpoint inhibitor-induced toxicities.

Robin Reschke, Alexander H Enk, Jessica C Hassel

|Dec 20, 2024
Prognostic Biomarkers in Evolving Melanoma Immunotherapy.

Robin Reschke, Alexander H Enk, Jessica C Hassel

|Jun 27, 2024
Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets.

Robin Reschke, Alexander H Enk, Jessica C Hassel

Pageof 3